Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001455244-10-000149
Filing Date
2010-12-29
Accepted
2010-12-29 18:39:41
Documents
1
Period of Report
2010-12-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4/A  
1 PRIMARY DOCUMENT edgar.xml 4/A 4632
  Complete submission text file 0001455244-10-000149.txt   6672
Mailing Address 12276 WILKINS AVENUE ROCKVILLE MD 20852
Business Address 12276 WILKINS AVENUE ROCKVILLE MD 20852 301-770-3099
NABI BIOPHARMACEUTICALS (Issuer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1226
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address
Aryeh Jason (Reporting) CIK: 0001376960 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-04829 | Film No.: 101279229